Empozin 3Xr 12.5mg/2.5mg Tab 14s
Empagliflozin linagliptin XR tablets 14s for type 2 diabetes.
Empozin 3Xr 12.5mg/2.5mg Tab 14s contain empagliflozin 12.5mg and linagliptin 2.5mg XR (SGLT2 and DPP-4 inhibitor) for type 2 diabetes. Take as directed; usually one tablet once daily. Swallow whole; do not crush or chew. Do not use in type 1 diabetes or diabetic ketoacidosis. Prescription only.
Purpose
Treatment of type 2 diabetes when prescribed.
Ingredients
Empagliflozin 12.5mg and linagliptin 2.5mg per tablet (XR); 14 tablets.
Warnings
Prescription only. Do not use in type 1 diabetes or diabetic ketoacidosis. Swallow whole.
Side Effects
Genital infection, urinary tract infection possible. Report abdominal pain or allergic reaction.
Storage Instructions
Store below 25°C in a dry place. Keep in original pack. Keep out of reach of children.
| Brand | Macter |
| Status | Active |
Related Products
